Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
GLP Collection
Bundle & saveApplies to every size
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot TZ05, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Labeled10mg
IdentityConfirmed
Measured10.25mg
TestedJul 19, 2026
View certificate →On recordLabeled30mg
IdentityConfirmed
Measured31.56mg
TestedJun 28, 2026
View certificate →On recordLabeled60mg
IdentityConfirmed
Measured64.13mg
TestedJun 16, 2026
View certificate →On recordLabeled30mg
IdentityConfirmed
Measured31.92mg
TestedJun 10, 2026
View certificate →Labeled60mg
IdentityConforms
Measured58.65 / 60.63mg
TestedOct 5, 2026
View certificate →On recordLabeled30mg
IdentityTirzepatide — Conforms
Measured29.87 / 27.83mg
TestedSep 29, 2026
View certificate →On recordLabeled10mg
IdentityConforms
Measured10.65 / 10.72mg
TestedSep 26, 2026
View certificate →On recordIdentityGLP-2
Measured66.69mg
TestedApr 26, 2026
View certificate →On recordTestedApr 23, 2026
View certificate →On recordMeasured11.62 / 11.68mg
TestedFeb 21, 2026
View certificate →On recordMeasured22.86 / 22.07mg
TestedFeb 20, 2026
View certificate →On recordTestedDec 29, 2025
View certificate →On recordTestedNov 11, 2025
View certificate →On recordTestedNov 11, 2025
View certificate →Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Lyophilized research material
Research Grade • Dual Incretin Peptide
Terminology: GLP-2 TZ is the Disguised Alpha catalog name associated with Tirz / tirzepatide research. It is distinct from the endogenous hormone GLP-2. Read the GLP2-Tirz research reference for scientific naming, primary publications and lot-documentation checks.
GLP-2 is a research peptide. It is studied in controlled lab models of GLP-1 receptor signaling and GIP pathways. It also fits work on incretin biology and glucose response. Other areas are appetite signals and energy balance. It is used in metabolic regulation work too.
Disguised Alpha GLP-2 is built for researchers who want more than a generic GLP listing. It is made for advanced metabolic research. In this work, identity, purity, handling, and records matter. Storage, batch tracking, and direct control of each order matter too.
GLP-2 is studied as a dual incretin research peptide. In these models, labs look at GLP-1 and GIP receptor pathways together. This makes it relevant to modern metabolic work on receptor cross-talk. It also fits studies of glucose signals. Other areas are appetite pathways, adipose signals, and energy balance.
The Dual Incretin Research Standard
GLP-2 is studied in combined pathway models. These models look at GLP-1 receptor signaling and GIP pathways at the same time. That makes GLP-2 a close fit for controlled lab studies of incretin biology. It also fits glucose response work. Other areas are adipose pathways and metabolic adaptation models.
Pathway 01
Studied in incretin models of glucose signals. Also used in appetite pathway work and metabolic response systems.
Pathway 02
Used in lab studies of insulinotropic signals and incretin cross-talk. It also fits adipose pathway work and metabolic regulation.
Quality
Reviewed for records, look, and storage needs. Label accuracy and fitness for release are checked before it ships.
| Compound | GLP-2 |
|---|---|
| Format | Lyophilized peptide research vial |
| Use Classification | Laboratory research use only |
GLP-2 is studied as a dual incretin peptide. Work on it covers both GLP-1 receptor signaling and GIP receptor pathways. Unlike single pathway models, dual pathway compounds let labs study how metabolic signal systems interact. This spans glucose response, appetite, and energy balance.
Interest in GLP-2-style compounds comes from links between several research areas. These include incretin signaling and pancreatic pathway models. Insulin response and gastric emptying research are two more. So are adipose tissue signals and central appetite pathways. Metabolic adaptation models are part of it too.
Incretin research often compares GLP-2 with GLP-1 focused compounds. It is also set next to broader multi-incretin peptides. These studies look at pathway selectivity and how receptor signals differ. They also look at potency and metabolic response.
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Characterized tirzepatide in receptor assays, animal models and an investigational clinical formulation. These results do not establish equivalence of this listing to a sponsor product.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
The listed milligrams refer to material per vial, not concentration or administration instructions. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy